These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 16816958)

  • 1. Reduction of tick infections with Anaplasma marginale and A. phagocytophilum by targeting the tick protective antigen subolesin.
    de la Fuente J; Almazán C; Blouin EF; Naranjo V; Kocan KM
    Parasitol Res; 2006 Dec; 100(1):85-91. PubMed ID: 16816958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of the tick protective antigen subolesin in anaplasma marginale- and A. phagocytophilum-infected host cells.
    de la Fuente J; Blouin EF; Manzano-Roman R; Naranjo V; Almazán C; Pérez de la Lastra JM; Zivkovic Z; Massung RF; Jongejan F; Kocan KM
    Ann N Y Acad Sci; 2008 Dec; 1149():27-35. PubMed ID: 19120168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaplasma marginale and Anaplasma phagocytophilum: Rickettsiales pathogens of veterinary and public health significance.
    Atif FA
    Parasitol Res; 2015 Nov; 114(11):3941-57. PubMed ID: 26346451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the tick protective antigen subolesin reduces vector infestations and pathogen infection by Anaplasma marginale and Babesia bigemina.
    Merino O; Almazán C; Canales M; Villar M; Moreno-Cid JA; Galindo RC; de la Fuente J
    Vaccine; 2011 Nov; 29(47):8575-9. PubMed ID: 21951878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression analysis for subolesin in Rhipicephalus microplus infected with Anaplasma marginale.
    Carvajal-de la Fuente V; Merino-Charrez O; Tovar-Carman E; Rodríguez-Camarillo SD; Lagunes-Quintanilla RE; Muñoz-Tenería FA; Contreras M; de la Fuente J
    Exp Appl Acarol; 2018 Oct; 76(2):229-241. PubMed ID: 30302627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of sequential coinfection with Anaplasma phagocytophilum and Anaplasma marginale in cattle.
    Hoar BR; Nieto NC; Rhodes DM; Foley JE
    Am J Vet Res; 2008 Sep; 69(9):1171-8. PubMed ID: 18764690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the tick/pathogen interface for developing new anaplasmosis vaccine strategies.
    Kocan KM; de la Fuente J; Blouin EF
    Vet Res Commun; 2007 Aug; 31 Suppl 1():91-6. PubMed ID: 17682853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccinomics Approach to the Identification of Candidate Protective Antigens for the Control of Tick Vector Infestations and
    Contreras M; Alberdi P; Fernández De Mera IG; Krull C; Nijhof A; Villar M; De La Fuente J
    Front Cell Infect Microbiol; 2017; 7():360. PubMed ID: 28848718
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccination of cattle with Anaplasma marginale derived from tick cell culture and bovine erythrocytes followed by challenge-exposure with infected ticks.
    de la Fuente J; Kocan KM; Garcia-Garcia JC; Blouin EF; Claypool PL; Saliki JT
    Vet Microbiol; 2002 Oct; 89(2-3):239-251. PubMed ID: 12243900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of genes in salivary glands of male Rhipicephalus (Boophilus)microplus in response to infection with Anaplasma marginale.
    Zivkovic Z; Esteves E; Almazán C; Daffre S; Nijhof AM; Kocan KM; Jongejan F; de la Fuente J
    BMC Genomics; 2010 Mar; 11():186. PubMed ID: 20298599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subolesin expression in response to pathogen infection in ticks.
    Zivkovic Z; Torina A; Mitra R; Alongi A; Scimeca S; Kocan KM; Galindo RC; Almazán C; Blouin EF; Villar M; Nijhof AM; Mani R; La Barbera G; Caracappa S; Jongejan F; de la Fuente J
    BMC Immunol; 2010 Feb; 11():7. PubMed ID: 20170494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major surface protein 1a effects tick infection and transmission of Anaplasma marginale.
    de la Fuente J; Garcia-Garcia JC; Blouin EF; McEwen BR; Clawson D; Kocan KM
    Int J Parasitol; 2001 Dec; 31(14):1705-14. PubMed ID: 11730800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection of endothelial cells with Anaplasma marginale and A. phagocytophilum.
    Munderloh UG; Lynch MJ; Herron MJ; Palmer AT; Kurtti TJ; Nelson RD; Goodman JL
    Vet Microbiol; 2004 Jun; 101(1):53-64. PubMed ID: 15201033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of Anaplasma / Ehrlichia Species of Cattle and Ticks in Aydın Region].
    Hoşgör M; Bilgiç HB; Bakırcı S; Ünlü AH; Karagenç T; Eren H
    Turkiye Parazitol Derg; 2015 Dec; 39(4):291-8. PubMed ID: 26809916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tick cell line as a powerful tool to screen the antimicrobial susceptibility of the tick-borne pathogen Anaplasma marginale.
    Alonso BI; Ventura ES; Esteves E; Galletti MFBM; Dall'Agnol B; Martins JR; Klafke G; Reck J; Fogaça AC; Daffre S
    Exp Parasitol; 2020 Oct; 217():107958. PubMed ID: 32730769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with proteins involved in tick-pathogen interactions reduces vector infestations and pathogen infection.
    Merino O; Antunes S; Mosqueda J; Moreno-Cid JA; Pérez de la Lastra JM; Rosario-Cruz R; Rodríguez S; Domingos A; de la Fuente J
    Vaccine; 2013 Dec; 31(49):5889-96. PubMed ID: 24084474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to Anaplasma marginale major surface proteins 1a and 1b inhibit infectivity for cultured tick cells.
    Blouin EF; Saliki JT; de la Fuente J; Garcia-Garcia JC; Kocan KM
    Vet Parasitol; 2003 Feb; 111(2-3):247-60. PubMed ID: 12531299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine.
    Lopez JE; Palmer GH; Brayton KA; Dark MJ; Leach SE; Brown WC
    Infect Immun; 2007 May; 75(5):2333-42. PubMed ID: 17339347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaplasmosis: focusing on host-vector-pathogen interactions for vaccine development.
    de la Fuente J; Ayoubi P; Blouin EF; Almazán C; Naranjo V; Kocan KM
    Ann N Y Acad Sci; 2006 Oct; 1078():416-23. PubMed ID: 17114750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of B-cell epitopes in the N-terminal repeated peptides of Anaplasma marginale major surface protein 1a and characterization of the humoral immune response of cattle immunized with recombinant and whole organism antigens.
    Garcia-Garcia JC; de la Fuente J; Kocan KM; Blouin EF; Halbur T; Onet VC; Saliki JT
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):137-51. PubMed ID: 15010223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.